A chemotherapy regimen consisting of dexamethasone, high-dose cytarabine (ARA-C) and cisplatin (Platinol), used for the treatment of relapsed and refractory … [Read more...]
Search Results for: K C
CK2 inhibitor CX-4945
An orally bioavailable small-molecule inhibitor of CK2 with potential antineoplastic activity. CK2 inhibitor CX-4945 selectively binds to and inhibits the … [Read more...]
cisplatin
An inorganic platinum agent (cis-diamminedichloroplatinum) with antineoplastic activity. Cisplatin forms highly reactive, charged, platinum complexes which … [Read more...]
cell cycle checkpoint / DNA repair antagonist IC83
A proprietary agent with potential antineoplastic activity. Cell cycle checkpoint/DNA repair antagonist IC83 IC83 inhibits cell cycle checkpoint/DNA repair … [Read more...]
carbon C 14 PF-00299804
A radioconjugate consisting of an orally bioavailable small-molecule inhibitor of the epidermal growth factor receptor (erbB or HER) family of tyrosine kinases … [Read more...]
carboplatin-Taxol regimen
A chemotherapy regimen consisting of carboplatin and paclitaxel (Taxol) used for the treatment of endometrial, epithelial ovarian, head and neck, and … [Read more...]
anti-HGF monoclonal antibody AMG 102
A fully human IgG2 monoclonal antibody directed against the human hepatocyte growth factor (HGF) with potential antineoplastic activity. Anti-HGF monoclonal … [Read more...]
anti-IGF-1R recombinant monoclonal antibody SCH 717454
A recombinant, fully human monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity. … [Read more...]
Anti-M-CSF monoclonal antibody MCS110
A humanized monoclonal antibody directed against macrophage colony-stimulating factor (M-CSF) with potential anti-osteolytic activity. Anti-M-CSF monoclonal … [Read more...]
anti-PDGFR alpha monoclonal antibody MEDI-575
A humanized monoclonal antibody directed against the platelet-derived growth factor receptor (PDGFR) alpha with potential antineoplastic activity. Anti-PDGFR … [Read more...]